Pain and pain relief in pediatric end-of-life care

Bringing Pain Relief to Children: Treatment Approaches

Volumn , Issue , 2006, Pages 59-83

  Collins, John J ^a   Frager, Gerri ^b  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Child; dying; end of life; evidence; life limiting; pain; palliative care; pediatric; symptoms

Indexed keywords

EID: 79951928209     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-59745-125-3_3     Document Type: Chapter

References (70)

1. World Health Organization. Cancer Pain Relief and Palliative Care in Children. Geneva: World Health Organization; 1998
2. Wolfe J, Grier HE, Klar N, et al. Symptoms and suffering at the end of life in children with cancer. N Engl J Med 2000;342:326-333
3. World Health Organization. The World Health Report. Geneva: World Health Organization; 1995
4. Hongo T,Watanabe C, Okada S. Analysis of the circumstances at the end of life in children with cancer: Symptoms, suffering and acceptance. Pediatr Int 2003;45: 60-64
5. McCallum DE, Byrne P, Bruera E. How children die in hospital. J Pain Symptom Manage 2000;20:417-423
6. Belasco J, Danz P, Drill A, Schmid W, Burkey E. Supportive care: Palliative care in children, adolescents, and young adults. J Palliat Care 2000;16:39-46
7. Collins JJ, Byrnes ME, Dunkel I, et al. The Memorial Symptom Assessment Scale (MSAS): Validation study in children aged 10-18. J Pain Symptom Manage 2000;19:363-367
8. Drake R, Frost J, Collins JJ. The symptoms of dying children. J Pain Symptom Manage 2003;27:6-10
9. Robinson WM, Ravilly S, Berde CB,Wohl ME. End-of-life care in cystic fibrosis. Pediatrics 1997;100:205-209
10. Ravilly S, Robinson W, Suresh S, Wohl ME, Berde CB. Chronic pain in cystic fibrosis. Pediatrics 1996;98:741-747
11. Collins JJ, Devine TB, Dick G, Johnson EA, Kilham HK. The measurement of symptoms in young children with cancer: The validation of the Memorial Symptom Assessment Scale in children aged 7-12. J Pain Symptom Manage 2002;23:10-16
12. Hunt AM. A survey of signs, symptoms and symptom control in 30 terminally ill children. Dev Med Child Neurol 1990;32:347-355
13. Oleske JM, Czarniecki L. Continuum of palliative care: Lessons from caring for children infected with HIV-1. Lancet 1999;354:1287-1290
14. Hirschfeld S, Moss H, Dragisic K, Pizzo PA. Pain in pediatric immunodeficiency virus infection: Incidence and characteristics in a single-institution pilot study. Pediatrics 1996;98:449-452
15. Massie RJ, Towns SJ, Bernard E, Chaitow J, Howman-Giles R, Van Asperen PP. The musculoskeletal complications of cystic fibrosis. J Paediatr Child Health 1998;34:467-470
16. McGrath PJ, Frager G. Psychological barriers to optimal pain management in infants and children. Clin J Pain 1996;12:135-141
17. Frager G, Collins JJ. Symptoms in life-limiting conditions. In: Hain R, Goldman A, Liben S, eds. Textbook of Pediatric Palliative Care. Oxford, UK: Oxford University Press; 2005
18. Champion GD, Goodenough B, von Baeyer CL, Thomas W. Measurement of pain by self-report. In: Finley GA, McGrath PJ, eds. Measurement of Pain in Infants and Children. Seattle, WA: IASP Press; 1998:123-160
19. Hicks CL, von Baeyer CL, Spafford P, van Korlaar I, Goodenough B. The Faces Pain Scale-Revised: Toward a common metric in pediatric pain measurement. Pain 2001; 93:173-183. The website www.painsourcebook.ca should referred to for further details including how to use The Faces Pain Scale-Revised in clinical practices
20. Collins JJ. Symptom control in life-limiting illness. In: Doyle D, Hanks GWC, Cherny NI, Calman KC, eds. Oxford Textbook of Palliative Medicine. New York: Oxford University Press; 2004:789-798
21. Gaffney A, McGrath PJ, Dick B. Measuring pain in children: Developmental and instrument issues. In: Schechter NL, Berde CB,Yaster M, eds. Pain in Infants, Children and Adolescents. Philadelphia: Lippincott,Williams, and Wilkins; 2003:128-141
22. Gauvain-Piquard A, Rodary C, Rezvani A, Serbouti S. The development of the DEGRR: A scale to assess pain in young children. Eur J Pain 1999;3:165-176
23. Breau LM, Finley GA, McGrath PJ, Camfield CS. Validation of the Non-communicating Children's Pain Checklist-Postoperative Version. Anesthesiology 2002;96: 523-526
24. Breau LM, McGrath PJ, Camfield CS, Finley GA. Psychometric properties of the Non-communicating Children's Pain Checklist-Revised. Pain 2002;99:349-357
25. Stallard P,Williams A, Velleman R, Lenton S, McGrath PJ. Brief report: Behaviors identified by caregivers to detect pain in noncommunicating children. Pediatr Psychol 2002;27:209-214
26. Bieri D, Reeve RA, Champion GD, Addicoat L, Ziegler JB. The Faces Pain Scale for the self-Assessment of the severity of pain experienced by children: Development, initial validation, and preliminary investigation for ratio scale properties. Pain 1990;41:139-150
27. Collins JJ, Grier HE, Kinney HC, Berde CB. Control of severe pain in terminal pediatric malignancy. J Pediatr 1995;126:653-657
28. Collins JJ, Grier HE, Sethna NF, Berde CB. Regional anesthesia for pain associated with terminal malignancy. Pain 1996;65:63-69
29. Siden H, Nalewajek P. High dose opioids in pediatric palliative care. J Pain Symptom Manage 2003;25:397-399
30. Miser AW, Moore L, Greene R. Prospective study of continuous intravenous and subcutaneous morphine infusions for therapy-related or cancer-related pain in children and young adults with cancer. Clin J Pain 1986;2:101-106
31. Miser AW, Dothage JA, Miser JS. Continuous intravenous fentanyl for pain control in children and young adults with cancer. Clin J Pain 1987;2:101-106
32. Miser AW, Miser JS. The use of oral methadone to control moderate and severe pain in children and young adults with malignancy. Clin J Pain 1985;1: 243-248
33. Miser AW, Miser JS, Clark BS. Continuous intravenous infusion of morphine sulfate for control of severe pain in children with terminal malignancy. J Pediatr 1980;96:930-933
34. Miser AW, Davis DM, Hughes CS, Mulne AF, Miser JS. Continuous subcutaneous infusion of morphine in children with cancer. Am J Dis Child 1983;137:383-385
35. Collins JJ, Dunkel I, Gupta SK, et al. Transdermal fentanyl in children with cancer: Feasibility, tolerability, and pharmacokinetic correlates. J Pediatr 1999;134:319-323
36. Hunt AM, Joel S, Dick G, Goldman A. Population pharmacokinetics of oral morphine and its glucuronides in children receiving morphine as immediate-release liquid or sustained-release tablets. J Pediatr 1999;135:47-55
37. Noyes M, Irving H. The use of transdermal fentanyl in pediatric oncology palliative care. Am J Hosp Palliat Care 2004;18:411-416
38. Hunt AM, Goldman A, Devine TB, Phillips M. Transdermal fentanyl for pain relief in a paediatric palliative care population. Palliat Med 2001;15:405-412
39. Oxford Centre for Evidence-based Medicine. Levels of evidence and grades of recommendations 2003. Available at: Http://cebm.jr2.ox.ac.uk/docs/levels.htm. Accessed Jan. 2005
40. Mackie AM, Coda BC, Hill HF. Adolescents use patient controlled analgesia effectively for relief for relief from prolonged oropharyngeal mucositis pain. Pain 1991;46:265-269
41. Collins JJ, Geake J, Grier HE, et al. Patient-controlled analgesia for mucositis pain in children: A three-period crossover study comparing morphine and hydromorphone. J Pediatr 1996;129:722-728
42. McGrath PA. Development of the World Health Organization Guidelines on Cancer Pain Relief and Palliative Care in Children. J Pain Symptom Manage 1996;12:87-92
43. Berde CB, Ablin AR, Glazer J, et al. American Academy of Pediatrics: Report of the subcommittee on disease-related pain in childhood cancer. Pediatrics 1990;86: 818-825
44. Ljungman G, Kreugar A, Gordh T, Berg T, Sorensen S, Rawal N. Treatment of pain in pediatric oncology: A Swedish nationwide survey. Pain 1996;68:385-394
45. Henley LD. End of life care in HIV-infected children who died in hospital. Dev World Bioeth 2002;2:38-54
46. Hilden JM, Emanuel EJ, Fairclough DL, et al. Attitudes and practices among pediatric oncologists regarding end-of-life care: Results of the 1998 American Society of Clinical Oncology Survey. J Clin Oncol 2001;19:205-212
47. Masera G, Spinetta JJ, Jankovic M, et al. Guidelines for assistance to terminally ill children with cancer: A report of the SIOP Working Committee on psychosocial issues in pediatric oncology. Med Pediatr Oncol 2000;34:271-273
48. Olness K, Gardner GG. Some guidelines for uses of hypnotherapy in pediatrics. Pediatrics 1978;62:228-233
49. Ellis JA, McCarthy P, Hershon L, et al. Pain practices: A cross-Canada survey of pediatric oncology centers. J Ped Oncol Nurs 2003;1:26-35
50. Cherny NI, Foley KM. Nonopioid and opioid analgesic pharmacotherapy of cancer pain. Hematol Oncol Clin North Am 1996;10:79-102
51. Berde CB, Lehn BM, Yee JD, et al. Patient controlled analgesia in children and adolescents: A randomized, prospective comparison with intramuscular morphine for postoperative analgesia. J Pediatr 1991;118:460-466
52. Galer BS, Coyle N, Pasternak GW, et al. Individual variability in the response to different opioids: Report of five cases. Pain 1992;49:87-91
53. Portenoy RK. Opioid tolerance and responsiveness: Research findings and clinical observations. In: Gebhart GF, Hammond DI, Jensen TS, eds. Progress in Pain Research and Management. Seattle, WA: IASP Press; 1994:615-619
54. Indelicato RA, Portenoy RK. Opiod rotation in the management of refractory cancer pain. J Clin Oncol 2003;21:87-91
55. Drake R, Longworth J, Collins JJ. Opioid rotation in children with cancer. J Palliat Med 2004;7:419-422
56. Inturrisi CE, Portenoy RK, Max M, Colburn WA, Foley KM. Pharmacokineticpharmacodynamic relationships of methadone infusions in patients with cancer pain. Clin Pharmacol Ther 1990;47:565-577
57. Ripamonti C, Groff L, Brunelli C, et al. Switching from morphine to oral methadone in treating cancer pain: What is the equianalgesic dose ratio? J Clin Oncol 1998;16:3216-3221
58. Frager G. Pediatric palliative care. In: Joishy SK, ed. Palliative Medicine Secrets. Philadelphia: Hanley and Belfus; 1999:157-173
59. Kenny NP, Frager G. Refractory symptoms and terminal sedation in children: Ethical issues and practical management. J Palliat Care 1996;12:40-45
60. Eide PK, Jorum E, Stubhaug A, et al. Relief of post-herpetic neuralgia with the N-methyl-D-Aspartic acid receptor antagonist ketamine: A double-blind cross-over comparison with morphine and placebo. Pain 1994;58:347-354
61. Persson J, Axelsson G, Hallin RG, et al. Beneficial effects of ketamine in a chronic pain state with allodynia. Pain 1995;60:217-222
62. Nelson KA, Park KM, Robinovitz E, et al. High dose dextromethorphan vs placebo in painful diabetic neuropathy and postherpetic neuralgia. Neurology 1997;48: 1212-1218
63. Eisenberg E, Pud D. Can patients with chronic neuropathic pain be cured by acute administration of the NMDA-receptor antagonist amantadine? Pain 1994;74: 37-39
64. Matson DD. Neurosurgery of Infancy and Childhood. Springfield, IL: Charles C Thomas; 1969
65. Paulino AC. Palliative radiotherapy in children with neuroblastoma. Pediatr Hematol Oncol 2003;20:111-117
66. Charron M, Brown M, Rowland P, Mirro J. Pain palliation with strontium-89 in children with metastatic disease. Med Pediatr Oncol 1996;26:393-396
67. Truog RD, Berde CB, Mitchell C, Grier HE. Barbiturates in the care of the terminally ill. N Engl J Med 1992;327:1678-1682
68. Truog RD, Burns JP, Shurin SB, Emanuel EJ. Ethical considerations in pediatric oncology. In: Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology. Philadelphia: Lippincott, Williams, and Wilikins; 2002:1411-1430
69. Siever BA. Pain management and potentially life-shortening analgesia in the terminally ill child: The ethical implications for pediatric nurses. J Pediatr Nurs 1994;5:307-312
70. Tobias JD. Propofol sedation for terminal care in a pediatric patient. Clin Ped 1997;36:291-293